Nehal Mohamed

Publication List Details

Period

1998 - 2005

Number

10

Co-Authors

A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1) (2005)

Repik, Alexander, Pincus, Steve E., Ghiran, Ionita, Nicholson-Weller, Anne, Asher, Damon R., Cerny, Anna M., ...

Complement receptor 1 (CR1) on the surface of human erythrocytes facilitates intravascular clearance of complement-opsonized pathogens. The need for complement activation can be circumvented by...

Heteropolymers: A New Class of Therapeutics for Treating Lethal Bacterial and Viral Infections (1998)

Mohamed, Nehal, Jones, Steven M., Li, Juan, Ferreira, Claudia, Chen, Xun, Kreiswirth, Barry, ...

Heteropolymers (HPs) contain a MAb directed against the Complement Receptor type 1 (CR1) on primate RBCs, chemically cross-linked to MAbs that recognize pathogens. Upon administration of HPs...

Inhibition of Staphylococcus aureus Adherence to Collagen under Dynamic Conditions

Mohamed, Nehal, Teeters, Mark A., Patti, Joseph M., Höök, Magnus, Ross, Julia M.

Staphylococcus aureus is the most common etiological agent of bacterial arthritis and acute osteomyelitis and has been shown to bind to type II collagen under static and dynamic conditions. We have...

Functional Analysis of the Staphylococcus aureus Collagen Adhesin B Domain

Snodgrass, James L., Mohamed, Nehal, Ross, Julia M., Sau, Subrata, Lee, Chia Y., Smeltzer, Mark S.

The Staphylococcus aureus collagen adhesin (CNA) occurs in at least four forms that differ in the number (one, two, three, or four) of B domains. The B domains contain 187 amino acids and are located...

Enhancement of Anthrax Lethal Toxin Cytotoxicity: a Subset of Monoclonal Antibodies against Protective Antigen Increases Lethal Toxin-Mediated Killing of Murine Macrophages

Mohamed, Nehal, Li, Juan, Ferreira, Claudia S., Little, Stephen F., Friedlander, Arthur M., Spitalny, George L., ...

We investigated the ability of using monoclonal antibodies (MAbs) against anthrax protective antigen (PA), an anthrax exotoxin component, to modulate exotoxin cytotoxic activity on target macrophage...

A High-Affinity Monoclonal Antibody to Anthrax Protective Antigen Passively Protects Rabbits before and after Aerosolized Bacillus anthracis Spore Challenge

Mohamed, Nehal, Clagett, Michelle, Li, Juan, Jones, Steven, Pincus, Steven, D'Alia, Giovanni, ...

We have developed a therapeutic for the treatment of anthrax using an affinity-enhanced monoclonal antibody (ETI-204) to protective antigen (PA), which is the central cell-binding component of the...

Inhibition of Staphylococcus aureus Adherence to Collagen under Dynamic Conditions

Mohamed, Nehal, Teeters, Mark A., Patti, Joseph M., Höök, Magnus, Ross, Julia M.

Staphylococcus aureus is the most common etiological agent of bacterial arthritis and acute osteomyelitis and has been shown to bind to type II collagen under static and dynamic conditions. We have...

Functional Analysis of the Staphylococcus aureus Collagen Adhesin B Domain

Snodgrass, James L., Mohamed, Nehal, Ross, Julia M., Sau, Subrata, Lee, Chia Y., Smeltzer, Mark S.

The Staphylococcus aureus collagen adhesin (CNA) occurs in at least four forms that differ in the number (one, two, three, or four) of B domains. The B domains contain 187 amino acids and are located...

Enhancement of Anthrax Lethal Toxin Cytotoxicity: a Subset of Monoclonal Antibodies against Protective Antigen Increases Lethal Toxin-Mediated Killing of Murine Macrophages

Mohamed, Nehal, Li, Juan, Ferreira, Claudia S., Little, Stephen F., Friedlander, Arthur M., Spitalny, George L., ...

We investigated the ability of using monoclonal antibodies (MAbs) against anthrax protective antigen (PA), an anthrax exotoxin component, to modulate exotoxin cytotoxic activity on target macrophage...

A High-Affinity Monoclonal Antibody to Anthrax Protective Antigen Passively Protects Rabbits before and after Aerosolized Bacillus anthracis Spore Challenge

Mohamed, Nehal, Clagett, Michelle, Li, Juan, Jones, Steven, Pincus, Steven, D'Alia, Giovanni, ...

We have developed a therapeutic for the treatment of anthrax using an affinity-enhanced monoclonal antibody (ETI-204) to protective antigen (PA), which is the central cell-binding component of the...